Does Shanghai Pharma Biotherapeutics sponsor H-1B workers?
VisaSignal shows official LCA filing activity found in the imported dataset. That activity can indicate historical immigration-related hiring signals, but it is not a promise of sponsorship.
Employer profile
Shanghai Pharma Biotherapeutics
Official filing activity, wage signals, roles, and source freshness in one place.
LCA
2
PERM
0
Median wage
$256,000
Last activity
Nov 17, 2025
Summary
Plain-language read
Shanghai Pharma Biotherapeutics has filed two Labor Condition Applications (LCA) in FY2026 Q1, all of which were certified. The primary role associated with these applications is General Manager, with both positions located in San Diego, CA. The median salary for these roles is reported at $256,000 per year. It's important to note that while LCA certification indicates compliance with wage and working condition requirements, it does not guarantee USCIS H-1B petition approval. Additionally, there are no PERM applications filed by the employer, which is relevant for green card processes. Always consult legal professionals for specific immigration guidance.
Wondering whether Shanghai Pharma Biotherapeutics sponsors H-1B? The H-1B sponsor checker reads any company against the same official LCA and PERM filing signals shown here.
Sources
Imported periods
Source context
LCA and PERM database lookupSearch official DOL LCA and PERM disclosure records by employer, role, SOC code, city, or state.PERM processing timesCompare employer PERM rows with current FLAG timing context.Prevailing wage timingReview the separate PWD queue that can precede PERM recruitment and frames wage research.Source statusCheck import recency, source URLs, row counts, and job status.About the dataRead normalization caveats before comparing filing signals.
Employer filing context
Shanghai Pharma Biotherapeutics H-1B and PERM research checkpoints
Use this section for searches such as "Shanghai Pharma Biotherapeutics H-1B", "Shanghai Pharma Biotherapeutics LCA", and "Shanghai Pharma Biotherapeutics PERM" before comparing individual case rows.
Activity mix
2 LCA rows and 0 PERM rows are normalized to this employer.
Latest source period: FY2026 Q1.
Search the full LCA & PERM disclosure database to see these rows next to every other employer’s official DOL filings.
Each H-1B petition behind these counts carries government filing fees. See the H-1B sponsor cost breakdown for the per-filing fee stack.
Role and worksite signal
Top observed role: General Manager. Top worksite: San Diego, CA.
See other H-1B sponsors in California.
Compare this with the H-1B/LCA and PERM drill-down tabs before treating counts as a hiring signal.
Normalization and source check
82% name match1 aliases
Primary source: DOL OFLC disclosure data. Last verified: .
Name matching is a normalization heuristic. Read the source methodology and import freshness before treating matched aliases as a complete sponsor history.
Filing trends
Shanghai Pharma Biotherapeutics filing volume
2 imported H-1B/LCA and PERM filings · median wage $256,000Too few records for a fiscal-year trend chart — see the case tabs for full rows.
Roles
Top official job titles
General Manager2
Worksites
Top locations
San Diego, CA2
Status mix
Case statuses
Certified2
Related sponsors
Sponsors adjacent to Shanghai Pharma Biotherapeutics
Employers with imported DOL LCA or PERM filings that also list California worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.
FAQ
Common questions
Does Shanghai Pharma Biotherapeutics file PERM cases?
The PERM count reflects imported DOL PERM disclosure rows for this normalized employer. Raw employer names and aliases are preserved so users can inspect normalization confidence.
What does VisaSignal show for Shanghai Pharma Biotherapeutics H-1B and PERM?
For Shanghai Pharma Biotherapeutics H-1B research, the page summarizes imported DOL LCA labor-condition rows. For Shanghai Pharma Biotherapeutics PERM research, it summarizes imported DOL permanent labor certification rows. Both include roles, worksites, wage signals, case-status mix, and the latest source period.
Does an LCA certification mean an H-1B petition was approved?
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
Does a PERM certification mean a green card was approved?
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
Can this data prove an employer will sponsor a candidate?
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.